Financials
Thursday, August 25, 2016
BRIEF-Viking Therapeutics enters into $12.5 million common stock purchase agreement with Aspire Capital
* Viking Therapeutics enters into $12.5 million common stock
purchase agreement with Aspire Capital
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment